Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NU6

Crystal Structure of HIV-1 Protease Mutant I54M with Antiviral Drug Amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 22-ID
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2007-07-24
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)1.0
Spacegroup nameP 21 21 2
Unit cell lengths58.120, 85.910, 46.100
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution10.000 - 1.160
R-factor0.1523
Rwork0.152
R-free0.18790
Structure solution methodAB INITIO
Starting model (for MR)2f8g
RMSD bond length0.016
RMSD bond angle0.033
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareMOLREP
Refinement softwareSHELXL-97
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0001.200
High resolution limit [Å]1.1601.160
Rmerge0.0720.357
<I/σ(I)>2
Completeness [%]91.858.9
Redundancy52.1
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP4.6298Crystal was grown by the hanging-drop vapor-diffusion method at room temperature, from a 2.2 mg/ml protein solution at pH 4.6 with 0.1M sodium acetate, 0.67M sodium chloride. The inhibitor was mixed with protease in a ratio 5:1 , VAPOR DIFFUSION, HANGING DROP, temperature 298K

232418

PDB entries from 2025-03-05

PDB statisticsPDBj update infoContact PDBjnumon